The Fordham site is one of Resolian’s largest bioanalytical centers.
Lab Description
The Fordham site employs 240 scientists operating from 8,000 square meters of purpose-built, state-of-the-art analytical labs.
This high-tech campus is in a beautiful rural setting just outside the British horseracing center of Newmarket and 20 minutes from the bioscience hub of Cambridge, UK.
How big is the Fordham, UK lab and how many scientists work there?
The Fordham, UK facility covers 8,000 square metres and is staffed by 240 scientists, making it one of Resolian's largest single-site bioanalytical operations.
What bioanalytical services does the Fordham, UK lab support?
Fordham, UK runs LC-MS and immunoassay work, including large molecule ligand binding assay (LBA) support, for both clinical and preclinical studies.
Is the Fordham, UK lab certified on specific platforms?
Yes. Fordham, UK holds Gyrolab Certified CRO Partner status and Certified Service Provider status on the Ella platform, so automated immunoassay work is backed by vendor-level certification.
Where is the Fordham, UK lab located?
Fordham is on Newmarket Road, Fordham, Ely, CB7 5WW, in Cambridgeshire, UK, close to the Cambridge life sciences cluster.
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.